Qualitative or quantitative protein defects in neuromuscular diseases
MONDO:001613930 clinical trials for this condition and its sub-types, 0 tagged with Qualitative or quantitative protein defects in neuromuscular diseases itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Qualitative or quantitative protein defects in neuromuscular diseases
-
Sarcoglycanopathy 3 trials · 10 incl. sub-types
4 sub-types
- Qualitative or quantitative defects of beta-sarcoglycan 0 trials · 5 incl. sub-types Sub-types →
- Qualitative or quantitative defects of gamma-sarcoglycan 1 trial · 4 incl. sub-types Sub-types →
- Qualitative or quantitative defects of alpha-sarcoglycan 0 trials · 3 incl. sub-types Sub-types →
- Qualitative or quantitative defects of delta-sarcoglycan 0 trials · 2 incl. sub-types Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan 0 trials · 8 incl. sub-types
1 sub-type
- Qualitative or quantitative defects of protein involved in O-glycosylation of alpha-dystroglycan 0 trials · 8 incl. sub-types Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of dystrophin 4 trials · 5 incl. sub-types
2 sub-types
-
Neuromuscular disease caused by qualitative or quantitative defects of titin 0 trials · 4 incl. sub-types
1 sub-type
- TTN-related myopathy 2 trials · 4 incl. sub-types Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of tropomyosin 0 trials · 4 incl. sub-types
5 sub-types
- TPM2-related myopathy 1 trial · 3 incl. sub-types Sub-types →
- Childhood-onset nemaline myopathy 1 trial · 2 incl. sub-types Sub-types →
- TPM3-related myopathy 1 trial Sub-types →
- Intermediate nemaline myopathy 0 trials Sub-types →
- Typical nemaline myopathy 0 trials Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin 0 trials · 3 incl. sub-types
4 sub-types
-
Neuromuscular disease caused by qualitative or quantitative defects of alpha-actin 0 trials · 2 incl. sub-types
5 sub-types
- Childhood-onset nemaline myopathy 1 trial · 2 incl. sub-types Sub-types →
- Severe congenital nemaline myopathy 0 trials · 1 incl. sub-types Sub-types →
- Adult-onset nemaline myopathy 0 trials
- Intermediate nemaline myopathy 0 trials Sub-types →
- Typical nemaline myopathy 0 trials Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of nebulin 0 trials · 2 incl. sub-types
5 sub-types
- Childhood-onset nemaline myopathy 1 trial · 2 incl. sub-types Sub-types →
- Severe congenital nemaline myopathy 0 trials · 1 incl. sub-types Sub-types →
- Adult-onset nemaline myopathy 0 trials
- Intermediate nemaline myopathy 0 trials Sub-types →
- Typical nemaline myopathy 0 trials Sub-types →
-
Collagen 6-related myopathy 1 trial
3 sub-types
- Bethlem myopathy 1A 0 trials
- Ullrich congenital muscular dystrophy 1A 0 trials
- Myosclerosis 0 trials
-
Neuromuscular disease caused by qualitative or quantitative defects of myofibrillar proteins 0 trials · 1 incl. sub-types
4 sub-types
- Qualitative or quantitative defects of desmin 0 trials · 1 incl. sub-types Sub-types →
- Qualitative or quantitative defects of alphaB-cristallin 0 trials
- Qualitative or quantitative defects of filamin C 0 trials Sub-types →
- Qualitative or quantitative defects of protein ZASP 0 trials Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of plectin 0 trials · 1 incl. sub-types
2 sub-types
-
Neuromuscular disease caused by qualitative or quantitative defects of selenoprotein N1 0 trials · 1 incl. sub-types
2 sub-types
- Multiminicore myopathy 1 trial Sub-types →
- Rigid spine syndrome 0 trials · 1 incl. sub-types Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of telethonin 0 trials · 1 incl. sub-types
2 sub-types
-
Alpha-actinopathy 0 trials
4 sub-types
- Cap myopathy 0 trials
- Congenital myopathy 2a, typical, autosomal dominant 0 trials
- Progressive scapulohumeroperoneal distal myopathy 0 trials
- Zebra body myopathy 0 trials
-
Caveolinopathy 0 trials
1 sub-type
-
2 sub-types
-
3 sub-types
- MYH7-related skeletal myopathy 0 trials
- Congenital myopathy 7A, myosin storage, autosomal dominant 0 trials
- Hyaline body myopathy 0 trials
-
2 sub-types
-
2 sub-types
- Brody myopathy 0 trials
- Myopathy due to calsequestrin and SERCA1 protein overload 0 trials
Most studied deeper sub-types
-
New drug aims to save hearts in duchenne muscular dystrophy
Disease control CompletedThis study tested an oral drug called ifetroban in 46 males aged 7 and older with Duchenne muscular dystrophy (DMD). The goal was to see if the drug is safe and can help prevent or treat heart problems, which are a leading cause of death in DMD. Participants received either ifetr…
Phase 2 • Sponsor: Cumberland Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Experimental drug ataluren tested for safety in duchenne MD patients
Disease control CompletedThis study tested the safety of a drug called ataluren (also known as Translarna) in 270 people with Duchenne muscular dystrophy caused by a specific type of genetic mistake (nonsense mutation). Participants had already taken ataluren in earlier studies. The goal was to monitor s…
Phase 3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Simple frailty quiz may help predict chemo risks for seniors with stomach or bowel cancer
Knowledge-focused CompletedThis study looked at whether two simple frailty questionnaires (G8 and VES-13) can predict serious side effects from chemotherapy in people 65 and older with gastrointestinal cancers. Researchers followed 72 patients receiving standard chemotherapy and checked their frailty, nutr…
Sponsor: Ankara Etlik City Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
New study tracks muscle decline in rare disease to guide future treatments
Knowledge-focused CompletedThis study followed 52 people with limb-girdle muscular dystrophy 2I (LGMD2I) for up to two years to learn more about how the disease changes over time. Researchers measured walking ability, muscle strength, heart function, and daily activities. The goal was to better understand …
Sponsor: Genethon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Health warnings in booze app put to the test
Knowledge-focused CompletedThis study looked at whether showing health warning messages in a mobile app where people buy alcohol affects their purchasing. Over 11,700 adults in Sweden took part. One group saw rotating health warnings, while the other saw standard messages. The researchers tracked purchases…
Sponsor: World Health Organization • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC